Recombinant multi-species UBE2G2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine UBE2G2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The modification of proteins with ubiquitin is an important cellular mechanism for targeting abnormal or short-lived proteins for degradation. Ubiquitination involves at least three classes of enzymes: ubiquitin-activating enzymes, or E1s, ubiquitin-conjugating enzymes, or E2s, and ubiquitin-protein ligases, or E3s. This gene encodes a member of the E2 ubiquitin-conjugating enzyme family. The encoded protein shares 100% sequence identity with the mouse counterpart. This gene is ubiquitously expressed, with high expression seen in adult muscle. Three alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, Jan 2011]
The Alternative Names of target: 1110003O05Rik,D10Xrf369,E2 ubiquitin-conjugating enzyme G2,UBC7,UBE2G2,Ubc7p,Ube2g2,Ubiquitin carrier protein G2,Ubiquitin-conjugating enzyme E2 G2,Ubiquitin-protein ligase G2

Target products collectionGo to UBE2G2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP11892-Ag-1/ GM-Tg-hg-IP11892-Ag-2 Human UBE2G2 protein Human
GM-Tg-rg-IP11892-Ag-1/ GM-Tg-rg-IP11892-Ag-2 Rat UBE2G2 protein Rat
GM-Tg-mg-IP11892-Ag-1/ GM-Tg-mg-IP11892-Ag-2 Mouse UBE2G2 protein Mouse
GM-Tg-cynog-IP11892-Ag-1/ GM-Tg-cynog-IP11892-Ag-2 Cynomolgus/Rhesus macaque UBE2G2 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP11892-Ag-1/ GM-Tg-felg-IP11892-Ag-2 Feline UBE2G2 protein Feline
GM-Tg-cang-IP11892-Ag-1/ GM-Tg-cang-IP11892-Ag-2 Canine UBE2G2 protein Canine
GM-Tg-bovg-IP11892-Ag-1/ GM-Tg-bovg-IP11892-Ag-2 Bovine UBE2G2 protein Bovine
GM-Tg-equg-IP11892-Ag-1/ GM-Tg-equg-IP11892-Ag-2 Equine UBE2G2 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP11892-Ag-1/ GM-Tg-hg-IP11892-Ag-2; GM-Tg-rg-IP11892-Ag-1/ GM-Tg-rg-IP11892-Ag-2;
GM-Tg-mg-IP11892-Ag-1/ GM-Tg-mg-IP11892-Ag-2; GM-Tg-cynog-IP11892-Ag-1/ GM-Tg-cynog-IP11892-Ag-2;
GM-Tg-felg-IP11892-Ag-1/ GM-Tg-felg-IP11892-Ag-2; GM-Tg-cang-IP11892-Ag-1/ GM-Tg-cang-IP11892-Ag-2;
GM-Tg-bovg-IP11892-Ag-1/ GM-Tg-bovg-IP11892-Ag-2; GM-Tg-equg-IP11892-Ag-1/ GM-Tg-equg-IP11892-Ag-2
Products Name UBE2G2 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name UBE2G2
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine UBE2G2 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.